# Talen Energy Corp: financial statements, quarterly

TLN · Nasdaq · CIK 1622536 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tln.md) · [Financials](/companies/tln/financials.md) · [Filings](/companies/tln/filings.md) · [Insiders](/companies/tln/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tln/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-03-31) | period not labelled (2023-09-30) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | [666](/filings/0001628280-24-047751.md) | [416](/filings/0001628280-25-023501.md) | [346](/filings/0001628280-25-038626.md) | [459](/filings/0001622536-25-000032.md) | [353 d](/filings/0001622536-26-000017.md) | [654](/filings/0001622536-26-000036.md) | [409](/filings/0001622536-26-000066.md) | [697](/filings/0001622536-25-000032.md) | [758 d](/filings/0001622536-26-000017.md) | [1,568](/filings/0001622536-26-000036.md) | [894](/filings/0001622536-26-000066.md) |
| Research and development | $m | not reported | [5.0](/filings/0001628280-24-047751.md) | not reported | [0.0](/filings/0001628280-24-036935.md) | [1.0](/filings/0001628280-24-047751.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | not reported | [7.0](/filings/0001628280-24-047751.md) | [25.0](/filings/0001628280-25-023501.md) | [27.0](/filings/0001628280-25-038626.md) | [158](/filings/0001622536-25-000032.md) | [16.0 d](/filings/0001622536-26-000017.md) | [(106)](/filings/0001622536-26-000036.md) | [66.0](/filings/0001622536-26-000066.md) | [263](/filings/0001622536-25-000032.md) | [(313) d](/filings/0001622536-26-000017.md) | [210](/filings/0001622536-26-000036.md) | [(72.0)](/filings/0001622536-26-000066.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | not reported | [(16.0)](/filings/0001628280-24-047751.md) | [69.0](/filings/0001628280-25-023501.md) | [112](/filings/0001628280-25-038626.md) | [11.0](/filings/0001622536-25-000032.md) | [(94.0) d](/filings/0001622536-26-000017.md) | [(52.0)](/filings/0001622536-26-000036.md) | [25.0](/filings/0001622536-26-000066.md) | [97.0](/filings/0001622536-25-000032.md) | [(17.0) d](/filings/0001622536-26-000017.md) | [18.0](/filings/0001622536-26-000036.md) | [(37.0)](/filings/0001622536-26-000066.md) |
| Net income | $m | [46.0](/filings/0001628280-24-047751.md) | [(76.0)](/filings/0001628280-24-047751.md) | [294](/filings/0001628280-25-023501.md) | [454](/filings/0001628280-25-038626.md) | [168](/filings/0001622536-25-000032.md) | [82.0 d](/filings/0001622536-26-000017.md) | [(135)](/filings/0001628280-25-023501.md) | [72.0](/filings/0001622536-26-000066.md) | [207](/filings/0001622536-25-000032.md) | [(363) d](/filings/0001622536-26-000017.md) | [63.0](/filings/0001622536-26-000066.md) | [(92.0)](/filings/0001622536-26-000066.md) |
| Diluted EPS | $ per share | not reported | [(1.30)](/filings/0001628280-24-047751.md) | [4.84](/filings/0001628280-25-023501.md) | [7.60](/filings/0001628280-25-038626.md) | [3.16](/filings/0001622536-25-000032.md) | not reported | [(2.94)](/filings/0001622536-26-000036.md) | [1.50](/filings/0001622536-26-000066.md) | [4.25](/filings/0001622536-25-000032.md) | not reported | [1.33](/filings/0001622536-26-000036.md) | [(2.00)](/filings/0001622536-26-000066.md) |
| Basic EPS | $ per share | not reported | [(1.30)](/filings/0001628280-24-047751.md) | [5.00](/filings/0001628280-25-023501.md) | [7.90](/filings/0001628280-25-038626.md) | [3.30](/filings/0001622536-25-000032.md) | not reported | [(2.94)](/filings/0001622536-26-000036.md) | [1.58](/filings/0001622536-26-000066.md) | [4.52](/filings/0001622536-25-000032.md) | not reported | [1.38](/filings/0001622536-26-000036.md) | [(2.00)](/filings/0001622536-26-000066.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | [0.4](/filings/0001628280-25-008786.md) | not reported | [0.6](/filings/0001628280-24-036935.md) | [0.6](/filings/0001628280-24-047751.md) | [0.3](/filings/0001622536-26-000017.md) | [0.3](/filings/0001628280-25-023501.md) | [0.1](/filings/0001628280-25-038626.md) | [0.5](/filings/0001622536-25-000032.md) | [0.7](/filings/0001622536-26-000066.md) | [1.0](/filings/0001622536-26-000036.md) | [0.2](/filings/0001622536-26-000066.md) |
| Current assets | $bn | not reported | [1.6](/filings/0001628280-25-008786.md) | not reported | [2.0](/filings/0001628280-24-036935.md) | [1.7](/filings/0001628280-24-047751.md) | [1.0](/filings/0001622536-26-000017.md) | [0.8](/filings/0001628280-25-023501.md) | [0.8](/filings/0001628280-25-038626.md) | [1.0](/filings/0001622536-25-000032.md) | [1.3](/filings/0001622536-26-000066.md) | [1.5](/filings/0001622536-26-000036.md) | [1.0](/filings/0001622536-26-000066.md) |
| Total assets | $bn | not reported | [7.1](/filings/0001628280-25-008786.md) | not reported | [7.1](/filings/0001628280-24-036935.md) | [6.8](/filings/0001628280-24-047751.md) | [6.1](/filings/0001622536-26-000017.md) | [5.9](/filings/0001628280-25-023501.md) | [5.8](/filings/0001628280-25-038626.md) | [6.1](/filings/0001622536-25-000032.md) | [10.9](/filings/0001622536-26-000066.md) | [11.0](/filings/0001622536-26-000036.md) | [15.1](/filings/0001622536-26-000066.md) |
| Current liabilities | $bn | not reported | [0.5](/filings/0001628280-25-008786.md) | not reported | [0.4](/filings/0001628280-24-036935.md) | [0.4](/filings/0001628280-24-047751.md) | [0.5](/filings/0001622536-26-000017.md) | [0.5](/filings/0001628280-25-023501.md) | [0.5](/filings/0001628280-25-038626.md) | [0.5](/filings/0001622536-25-000032.md) | [1.1](/filings/0001622536-26-000066.md) | [1.2](/filings/0001622536-26-000036.md) | [1.3](/filings/0001622536-26-000066.md) |
| Total liabilities | $bn | not reported | [4.6](/filings/0001628280-25-008786.md) | not reported | [4.5](/filings/0001628280-24-036935.md) | [4.4](/filings/0001628280-24-047751.md) | [4.7](/filings/0001622536-26-000017.md) | [4.7](/filings/0001628280-25-023501.md) | [4.6](/filings/0001628280-25-038626.md) | [4.6](/filings/0001622536-25-000032.md) | [9.8](/filings/0001622536-26-000066.md) | [9.9](/filings/0001622536-26-000036.md) | [13.4](/filings/0001622536-26-000066.md) |
| Long-term debt | $bn | not reported | [2.8](/filings/0001628280-25-008786.md) | not reported | [2.6](/filings/0001628280-24-036935.md) | [2.6](/filings/0001628280-24-047751.md) | [3.0](/filings/0001622536-26-000017.md) | [3.0](/filings/0001628280-25-023501.md) | [3.0](/filings/0001628280-25-038626.md) | [3.0](/filings/0001622536-25-000032.md) | [6.8](/filings/0001622536-26-000066.md) | [6.8](/filings/0001622536-26-000036.md) | [9.5](/filings/0001622536-26-000066.md) |
| Current portion of debt | $bn | not reported | [0.0](/filings/0001628280-25-008786.md) | not reported | [0.0](/filings/0001628280-24-036935.md) | [0.0](/filings/0001628280-24-047751.md) | [0.0](/filings/0001622536-26-000017.md) | [0.0](/filings/0001628280-25-023501.md) | [0.0](/filings/0001628280-25-038626.md) | [0.0](/filings/0001622536-25-000032.md) | [0.0](/filings/0001622536-26-000066.md) | [0.0](/filings/0001622536-26-000036.md) | [0.0](/filings/0001622536-26-000066.md) |
| Short-term borrowings | $bn | not reported | [0.0](/filings/0001628280-25-008786.md) | not reported | [0.0](/filings/0001628280-24-036935.md) | [0.0](/filings/0001628280-24-047751.md) | [0.0](/filings/0001628280-25-008786.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [2.4](/filings/0001628280-24-047751.md) | [2.5](/filings/0001628280-25-008786.md) | [2.8](/filings/0001622536-25-000032.md) | [2.5](/filings/0001628280-24-036935.md) | [2.4](/filings/0001628280-24-047751.md) | [1.4](/filings/0001622536-26-000017.md) | [1.2](/filings/0001628280-25-023501.md) | [1.2](/filings/0001628280-25-038626.md) | [1.5](/filings/0001622536-25-000032.md) | [1.1](/filings/0001622536-26-000066.md) | [1.1](/filings/0001622536-26-000036.md) | [1.6](/filings/0001622536-26-000066.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2022 (2016-06-30) | Q3 FY2022 (2016-09-30) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [11.0 d](/filings/0001622536-16-000148.md) | [342 d](/filings/0001622536-16-000174.md) | [173](/filings/0001628280-25-023501.md) | [(23.0) d](/filings/0001628280-25-038626.md) | [96.0 d](/filings/0001622536-25-000032.md) | [10.0 d](/filings/0001622536-26-000017.md) | [119](/filings/0001622536-26-000036.md) | [(184) d](/filings/0001622536-26-000066.md) | [489 d](/filings/0001622536-25-000032.md) | [280 d](/filings/0001622536-26-000017.md) | [461](/filings/0001622536-26-000036.md) | [(434) d](/filings/0001622536-26-000066.md) |
| Capital expenditure | $m | [169 d](/filings/0001622536-16-000148.md) | [68.0 d](/filings/0001622536-16-000174.md) | [25.0](/filings/0001628280-25-023501.md) | [20.0 d](/filings/0001628280-25-038626.md) | [13.0 d](/filings/0001622536-25-000032.md) | [27.0 d](/filings/0001622536-26-000017.md) | [18.0](/filings/0001622536-26-000036.md) | [33.0 d](/filings/0001622536-26-000066.md) | [21.0 d](/filings/0001622536-25-000032.md) | [26.0 d](/filings/0001622536-26-000017.md) | [42.0](/filings/0001622536-26-000036.md) | [139 d](/filings/0001622536-26-000066.md) |
| Share repurchases | $m | not reported | not reported | [30.0](/filings/0001628280-25-023501.md) | [624 d](/filings/0001628280-25-038626.md) | [302 d](/filings/0001622536-25-000032.md) | [1,002 d](/filings/0001622536-26-000017.md) | [83.0](/filings/0001622536-26-000036.md) | [20.0 d](/filings/0001622536-26-000066.md) | [0.0 d](/filings/0001622536-25-000032.md) | [0.0 d](/filings/0001622536-26-000017.md) | [100](/filings/0001622536-26-000036.md) | [198 d](/filings/0001622536-26-000066.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2022 (2016-03-31) | Q2 FY2022 (2016-06-30) | Q3 FY2022 (2016-09-30) | period not labelled (2023-09-30) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [129](/filings/0001622536-16-000122.md) | [129](/filings/0001622536-16-000148.md) | [130](/filings/0001622536-16-000174.md) | [59.0](/filings/0001628280-24-047751.md) | [60.7](/filings/0001628280-25-023501.md) | [59.8](/filings/0001628280-25-038626.md) | [53.2](/filings/0001622536-25-000032.md) | [45.8](/filings/0001622536-26-000036.md) | [47.9](/filings/0001622536-26-000066.md) | [48.6](/filings/0001622536-25-000032.md) | [47.4](/filings/0001622536-26-000036.md) | [45.9](/filings/0001622536-26-000066.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 47,914,259 at 2026-08-05, from the cover of the [10-Q filed 2026-08-05](/filings/0001622536-26-000066.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.